Skip to main content

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

MNPR holding history

Monopar Therapeutics in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overviewAll 13F holders of MNPRFull Q2 2026 holdings

Shares (Q2 2026)
157,423
Value
$14.6M
% of portfolio
0.3%
Quarters held
1
Since Q2 2026
Holdings of MNPR by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026157,423$14.6M0.3%+157,423NewHolders